Questions

1. MRI Findings & Diagnosis:
   • Heterogeneous high-signal intensity (hyperintensity) on T2/STIR within the proximal femoral metaphysis and femoral neck, representing acute intraosseous inflammatory exudate and bone marrow edema.
   • Associated subperiosteal fluid accumulation and surrounding soft-tissue edema.
   • Diagnosis: Acute hematogenous osteomyelitis of the right proximal femur.
2. Microbiology & Antimicrobial Regimen:
   • Most common pathogen: Staphylococcus aureus (>70-80% of cases; methicillin-susceptible [MSSA] or methicillin-resistant [MRSA]).
   • Empirical Regimen:
     • If low community MRSA prevalence (<10%): Cefazolin $100\text{--}150\text{ mg/kg/day}$ IV divided q8h (or Cloxacillin $150\text{--}200\text{ mg/kg/day}$ IV divided q6h).
     • If high community MRSA prevalence (>10%) or severe sepsis: Vancomycin $60\text{ mg/kg/day}$ IV divided q6h (target trough: $15\text{--}20\ \mu\text{g/mL}$) OR Clindamycin $40\text{ mg/kg/day}$ IV divided q8h (if local erythromycin/clindamycin resistance <10%).
     • Total duration: 3 to 4 weeks (minimum 2–3 weeks IV or early transition to high-dose oral therapy once afebrile for 48 hours and CRP declines by >50%).
3. Anatomical Basis of Secondary Septic Arthritis:
   • The hip joint capsule inserts distally beyond the epiphyseal plate onto the femoral neck, making the proximal femoral metaphysis entirely intracapsular.
   • Exudate under pressure penetrates the thin metaphyseal cortex through trans-cortical Volkmann's canals directly into the synovial space, bypassing periosteum and producing secondary septic arthritis with high risk of tamponade-induced avascular necrosis of the femoral head.
4. Indications for Surgical Intervention:
   • Presence of a well-defined subperiosteal, intraosseous, or soft-tissue abscess on imaging.
   • Concomitant septic arthritis of the hip requiring urgent arthrotomy/arthroscopic washout.
   • Failure of clinical improvement (persistent fever, worsening pain) and failure of CRP to decline after 48 to 72 hours of appropriate intravenous antibiotics.

flowchart TD
    A[Hematogenous Seeding into Metaphyseal Sinusoids] --> B[Sluggish Blood Flow & Bacterial Deposition]
    B --> C[Intramedullary Suppuration & Increased Pressure]
    C --> D[Extension via Haversian / Volkmann Canals]
    D --> E{Metaphyseal Location}
    E -->|Intracapsular: Proximal Femur / Proximal Humerus| F[Secondary Pyogenic Septic Arthritis]
    E -->|Extracapsular: Distal Femur / Proximal Tibia| G[Subperiosteal Abscess Formation]
    F --> H[Increased Intra-articular Pressure]
    H --> I[Chondrolysis & Avascular Necrosis of Femoral Head]

1. Identification & Clinical Quantification:
   • Deformity: Genu Valgum ("Knock-knees").
   • Clinical Measurement: Intermalleolar Distance (IMD), measured as the distance (in centimeters) between the medial malleoli of both ankles when the child stands erect with patellae facing directly forward and medial femoral condyles (knees) lightly touching.
2. Physiological Evolution of Tibiofemoral Angle:
   • Birth to 18–24 months: Physiological Genu Varum (bowlegs; maximum varus of $10^\circ\text{--}15^\circ$ at birth, correcting to neutral by 18–24 months).
   • 18 to 24 months: Neutral mechanical axis ($0^\circ$).
   • 3 to 4 years: Physiological Genu Valgum (peaks at $10^\circ\text{--}12^\circ$ valgus; intermalleolar distance up to $6\text{--}8\text{ cm}$).
   • 6 to 7 years: Spontaneous regression settling into adult alignment ($5^\circ\text{--}7^\circ$ valgus; IMD $<2\text{--}3\text{ cm}$).
3. Pathological Causes:
   • Nutritional or hypophosphatemic rickets / renal osteodystrophy.
   • Post-traumatic epiphyseal growth arrest or asymmetric overgrowth (e.g., Cozen's fracture of proximal tibial metaphysis).
   • Skeletal dysplasia (e.g., spondyloepiphyseal dysplasia, Morquio syndrome, achondroplasia).
   • Lysosomal storage disorders or osteogenesis imperfecta.
4. Surgical Indications & Technique:
   • Indications:
     • Intermalleolar distance (IMD) $>8\text{--}10\text{ cm}$ persisting beyond 7–8 years of age.
     • Mechanical axis deviation (MAD) falling into Zone 2 or 3 (lateral to the lateral tibial plateau) on long-leg standing radiograph.
     • Progressive asymmetric deformity, functional gait disability, patellofemoral maltracking/subluxation, or joint pain.
   • Surgical Modality: Guided growth (temporary hemiepiphysiodesis) using tension-band plates (8-plates) or staples placed across the medial distal femoral and/or proximal tibial physis.

1. Trimester-Specific APPD Classification:
   • Second Trimester (16–27 weeks):
     • Mild: $4\text{ to }<7\text{ mm}$
     • Moderate: $7\text{ to }10\text{ mm}$
     • Severe: $>10\text{ mm}$
   • Third Trimester ($\ge 28$ weeks):
     • Mild: $7\text{ to }<9\text{ mm}$ (Patient's values of $8.2\text{ mm}$ and $7.8\text{ mm}$ represent Mild Antenatal Hydronephrosis)
     • Moderate: $9\text{ to }15\text{ mm}$
     • Severe: $>15\text{ mm}$
2. Society for Fetal Urology (SFU) Grading:
   • Grade 0: Normal kidney, no renal pelvic dilatation.
   • Grade 1: Splitting of renal pelvis only (dilatation confined to the renal pelvis).
   • Grade 2: Dilatation of the renal pelvis and major calyces.
   • Grade 3: Dilatation of renal pelvis, major calyces, and minor calyces; renal parenchyma thickness is normal.
   • Grade 4: Dilatation of renal pelvis and calyces accompanied by renal parenchymal thinning.
3. Antenatal Surveillance & Delivery Plan:
   • Surveillance: Repeat targeted fetal ultrasound at 36 to 37 weeks of gestation to evaluate progression of APPD, calyceal dilation, and amniotic fluid volume.
   • Delivery: Standard obstetric indications; spontaneous or planned vaginal delivery at term ($39\text{--}40$ weeks) in a center with pediatric surgical and radiological facilities. Fetal hydronephrosis alone is never an indication for early induction or Cesarean delivery unless complicated by severe oligohydramnios.
4. Postnatal Protocol:
   • Timing of initial USG: Perform between 48 hours and 7 days of life. Do not image within the first 48 hours because physiological neonatal oliguria and low glomerular filtration rate cause false-negative underestimation of dilatation (unless bilateral severe hydronephrosis or suspected Posterior Urethral Valves).
   • Indications for VCUG:
     • High-grade hydronephrosis (SFU Grade 3 or 4, or APPD $>10\text{ mm}$ postnatally).
     • Presence of hydroureter or dilated ureter.
     • Abnormal bladder wall thickening, trabeculations, or dilated posterior urethra.
     • Bilateral moderate-to-severe hydronephrosis.
     • Occurrence of a culture-proven febrile urinary tract infection.

1. Syndromic Diagnosis & Maneuver:
   • Diagnosis: Bladder and Bowel Dysfunction (BBD) / Dysfunctional Elimination Syndrome (DES).
   • Maneuver: Vincent's Curtsy (perineal compression maneuver where the child squats down and presses the heel into the perineal floor to mechanically occlude the urethra and inhibit detrusor contraction).
2. Pathophysiological Mechanisms:
   • Direct Mechanical Compression: A chronically distended rectum full of hard fecal matter compresses the base and posterior wall of the bladder and bladder neck, causing bladder floor elevation and trigonal irritation.
   • Detrusor Overactivity & Dyssynergia: Common pelvic floor innervation (S2–S4 via pudendal and pelvic nerves) leads to cross-reflex sensitization; constant rectal loading triggers involuntary, uninhibited detrusor contractions.
   • Stasis and Incomplete Voiding: Tonic contraction of the external urethral sphincter to prevent incontinence creates functional bladder outflow obstruction, leading to elevated post-void residual volume, bladder wall hypertrophy, and failure of wash-out, which promotes recurrent ascending bacterial colonization.
3. Calculation of Expected Bladder Capacity & PVR Interpretation:
   $$ > \begin{aligned} > \text{Expected Bladder Capacity (EBC)} &= [\text{Age in years} + 1] \times 30\text{ mL (Koff's Formula)} \\ > &= [5 + 1] \times 30 \\ > &= \mathbf{180\text{ mL}} > \end{aligned} > $$
   • Interpretation of PVR: An acceptable normal PVR in a child is $<5\text{--}10\text{ mL}$ or $<10\%$ of bladder capacity. Her residual volume of $28\text{ mL}$ represents $15.5\%$ of expected bladder capacity, confirming significant incomplete bladder emptying.
4. Management Plan:
   • Step 1: Aggressive Management of Constipation (Cornerstone):
     • Disimpaction followed by maintenance laxative: Polyethylene Glycol 3350 (PEG without electrolytes) at $0.5\text{--}1.0\text{ g/kg/day}$ orally once daily, adjusted to produce 1 to 2 soft, painless Bristol Type 4 stools daily, continued for a minimum of 3 to 6 months.
     • High dietary fiber ($5 + 5 = 10\text{ g/day}$) and generous oral fluid intake.
   • Step 2: Urological Behavioral Modification (Urotherapy):
     • Timed voiding regimen: scheduled voiding every 2 to 3 hours by the clock.
     • Optimal toilet posture: relaxed seating with a footstool providing firm foot support and $35^\circ\text{--}45^\circ$ hip flexion to completely relax the levator ani and pelvic floor muscles.
   • Step 3: Pharmacotherapy for Detrusor Overactivity:
     • If urgency/incontinence persists after full resolution of fecal impaction, start an antimuscarinic: Oxybutynin $0.1\text{ to }0.2\text{ mg/kg/dose}$ orally twice to thrice daily (maximum $5\text{ mg}$ TID). Caution: Never start antimuscarinics before resolving constipation, as it worsens fecal loading.
   • Step 4: Infection Prophylaxis:
     • Nitrofurantoin $1\text{--}2\text{ mg/kg}$ orally once at bedtime (or Cotrimoxazole $2\text{ mg/kg}$ of trimethoprim component) until bowel habits and voiding mechanics normalize.

1. Diagnosis & Embryology:
   • Diagnosis: Second Branchial Cleft Fistula / Sinus (accounts for $>90\%$ of all branchial apparatus anomalies).
   • Embryological Defect: Failure of complete obliteration of the second branchial cleft (cervical sinus of His) and the second pharyngeal pouch.
2. Anatomical Course of the Tract:
   • Originates at the external cutaneous punctum along the anterior border of the lower third of the sternocleidomastoid muscle.
   • Ascends through subcutaneous fat, pierces the platysma, and ascends along the carotid sheath superficial to the carotid sheath fascia.
   • Courses deep to the platysma and crosses superficial to the hypoglossal nerve (CN XII) and glossopharyngeal nerve (CN IX).
   • Dips between the bifurcation of the carotid arteries: passes superficial to the internal carotid artery and deep to the external carotid artery.
   • Passes superficial to the stylopharyngeus muscle and terminates internally in the supratonsillar fossa / tonsillar fossa of the oropharynx.
3. Preoperative Imaging Modalities:
   • High-resolution Neck Ultrasonography (HR-USG): Initial investigation to assess tract patency, identify cystic dilatation, and rule out thyroid/vascular anomalies.
   • Fistulogram / Sinogram (fluoroscopic contrast injection through the external opening) OR Contrast-enhanced MRI / CT Neck: To delineate the complete 3D trajectory and its relation to the carotid bifurcation.
4. **Surgical Technique &

1. Diagnosis and Pathophysiology:
   • Diagnosis: Acute Compartment Syndrome (ACS) of the forearm (specifically the deep volar compartment).
   • Pathophysiology: Elevated tissue fluid pressure within an inelastic, closed fascial/osteofascial compartment or rigid circumferential cast exceeds capillary perfusion pressure (typically $>30\text{ mmHg}$ or within $30\text{ mmHg}$ of diastolic blood pressure, $\Delta P = \text{DBP} - P_{\text{compartment}} \le 30\text{ mmHg}$), leading to microvascular compromise, cellular hypoxia, tissue ischemia, irreversible nerve injury within 4–6 hours, and muscle necrosis within 6–8 hours (Volkmann ischemic contracture).
2. Clinical Monitoring ("6 Ps"):
   • Pain: Disproportionate to the underlying injury, refractory to escalating doses of opioids.
   • Passive Stretch Pain: Exquisite pain elicited on passive stretch of the ischemic compartmental muscles (forearm flexors/extensors) — earliest and most sensitive clinical sign.
   • Paresthesia: Decreased sensation or numbness along peripheral nerve distributions traversing the compartment (median/ulnar nerve).
   • Pallor: Distal extremity coolness, pale or mottled skin with prolonged capillary refill ($>3$ seconds).
   • Paralysis / Paresis: Inability to actively contract muscles; late sign indicating established ischemic necrosis.
   • Pulselessness: Loss of distal arterial pulse; extremely late sign signifying irreversible terminal injury.
3. Immediate Step-by-Step Bedside Management:
   • Positioning: Keep the extremity elevated strictly at heart level (avoid high elevation above the heart, which further reduces arterial perfusion pressure; avoid dependent positioning, which increases venous congestion).
   • Bivalving the Cast: Cut the rigid circumferential cast along both medial and lateral borders along its entire length.
   • Splitting Underlying Padding: Cut the cotton/stockinette down to bare skin along the entire length (cotton padding alone can maintain up to 30–40% of the constriction pressure; bivalving and cutting padding reduces compartment pressure by $>70\%$).
   • Spreading the Shell: Gently spread the cast halves apart.
   • Reassessment & Emergency Escalation: Re-evaluate neurovascular status every 15–30 minutes. If pain, neurovascular deficits, or elevated compartment pressure persist ($>30\text{ mmHg}$ or $\Delta P \le 30\text{ mmHg}$), perform emergency surgical decompression (volar/dorsal forearm fasciotomy).
4. Comparison of Casting Materials:
   • Plaster of Paris (Gypsum - Calcium Sulfate Hemihydrate):
     • Setting time: 3 to 5 minutes (quick setting).
     • Full cure / drying time: 24 to 72 hours before full weight-bearing capacity is achieved.
     • Exothermic potential: Generates significant heat during crystallization ($CaSO_4 \cdot \frac{1}{2}H_2O + 1\frac{1}{2}H_2O \rightarrow CaSO_4 \cdot 2H_2O$); higher water temperatures ($>25^\circ\text{C}$) or thick plaster layers markedly increase thermal burn risk.
   • Synthetic Cast (Fiberglass / Polyurethane-coated resin):
     • Setting time: 3 to 4 minutes.
     • Full cure / drying time: 20 to 30 minutes to achieve full weight-bearing strength.
     • Exothermic potential: Lower exothermic burn risk compared to thick plaster; lighter, radiolucent, and water-resistant.

1. Radiological Features and Diagnosis:
   • Radiological Findings: Multiple radiolucent, cystic, air-filled bowel loops occupying the left hemithorax, marked mediastinal and cardiac shift to the contralateral (right) hemithorax, ipsilateral lung collapse, compressed contralateral lung, and a pauci-gas or gasless scaphoid abdomen. An orogastric tube tip may be curled inside the thoracic cavity.
   • Definitive Diagnosis: Left-sided Congenital Diaphragmatic Hernia (Bochdalek hernia).
2. Resuscitation Precautions and Stabilization:
   • Strictly Contraindicated: Positive-pressure bag-and-mask ventilation (IPPV via mask) — it forces gas into the intrathoracic stomach and bowel loops, worsening mediastinal compression and lung collapse.
   • Immediate Airway Step: Immediate endotracheal intubation in the delivery room without preceding bag-and-mask ventilation.
   • Gastrointestinal Decompression: Prompt insertion of a large-bore (10–12 Fr) continuous-suction or vented orogastric/nasogastric tube to decompress the stomach and bowel loops.
3. Anatomical Subtypes and Prevalence:
   • Posterolateral Defect (Bochdalek Hernia): 85–90% of cases; predominantly left-sided (80–85%), right-sided (10–15%), bilateral ($<2\%$). Results from failure of the pleuroperitoneal canal/membrane to close at 8–10 weeks of gestation.
   • Anterior / Retrosternal Defect (Morgagni / Morgagni-Larrey Hernia): 2–6% of cases; occurs through the space of Larrey anteriorly between the xiphoid and costal diaphragmatic margins; often right-sided and presents later in infancy or childhood.
   • Central Diaphragmatic Defect (Septum Transversum Defect): 1–2% of cases; absence of the central tendon.
   • Diaphragmatic Eventration: Thinning and upward displacement of diaphragmatic musculature without true herniation orifice.
4. Pathophysiology and Target Oxygenation:
   • Primary Determinant of Mortality: Pulmonary hypoplasia (reduced branching of airways, reduced alveolar surface area, and medial hypertrophy of pulmonary arterial vasculature) coupled with persistent pulmonary hypertension of the newborn (PPHN).
   • Target Pre-ductal Parameters (Gentle Ventilation Strategy):
     • Pre-ductal $SpO_2$: 85–95% (right upper extremity).
     • Target arterial $PaCO_2$: 45–55 mmHg (permissive hypercapnia with $pH \ge 7.25$).
     • Avoid high peak inspiratory pressures ($PIP < 25\text{ cmH}_2O$, tidal volume 4–5 mL/kg) to minimize ventilator-induced lung injury (VILI) and pneumothorax in the hypoplastic lungs.

1. Condition and Anatomical Components:
   • Condition: Congenital Talipes Equinovarus (CTEV) / Congenital Clubfoot.
   • Components (C-A-V-E):
     • C - Cavus: Exaggeration of the medial longitudinal arch caused by plantarflexion of the first metatarsal relative to the hindfoot.
     • A - Adductus: Medial deviation/adduction and supination of the forefoot and midfoot at the tarsometatarsal and midtarsal (Chopart) joints.
     • V - Varus: Inversion and adduction of the calcaneus (hindfoot) beneath the talus (subtalar joint).
     • E - Equinus: Fixed plantarflexion of the hindfoot at the ankle (tibiotalar) joint due to contracture of the Achilles tendon.
2. Clinical Differentiation:
   • Positional (Postural) Clubfoot: The foot is supple and can be passively dorsiflexed and everted so that the dorsal aspect of the foot readily touches the anterior tibial surface; it results from intrauterine packing/oligohydramnios without intrinsic soft-tissue contractures or bony dysplasia.
   • Structural (Congenital) Clubfoot: The foot is rigid, displays deep skin creases over the medial midfoot and posterior ankle, exhibits a hypoplastic calf, and cannot be passively corrected to neutral or overcorrected past neutral due to fixed capsular, ligamentous, and tendinous contractures.
3. Associated Conditions:
   • Myelomeningocele / Spina bifida / Spinal dysraphism.
   • Arthrogryposis multiplex congenita (Amyoplasia).
   • Congenital myotonic dystrophy / Spinal muscular atrophy (SMA).
   • Chromosomal anomalies / Genetic syndromes (e.g., Trisomy 18, Larsen syndrome, Moebius syndrome).
4. Ponseti Conservative Casting Protocol:
   • Order of Correction: Correct Cavus first, followed simultaneously by Adductus and Varus, and finally Equinus (C $\rightarrow$ A/V $\rightarrow$ E).
   • Fulcrum of Manipulation: Counter-pressure is applied exclusively against the lateral aspect of the head of the talus while the forefoot is abducted in supination. The calcaneus is never directly grasped or manipulated (avoid locking calcaneus under the talus).
   • Serial Casting: Long-leg casts extending to upper thigh with knee in $90^\circ$ flexion, changed every 5 to 7 days (usually 4–6 casts total).
   • Indication for Percutaneous Achilles Tenotomy: Indicated when forefoot adduction, cavus, and hindfoot varus are fully corrected (abduction reaches $\ge 60^\circ$), but residual hindfoot equinus remains with ankle dorsiflexion $<10^\circ$–$15^\circ$ above neutral (required in $>85\text{--}90\%$ of patients). Performed under local anesthesia, followed by final cast for 3 weeks before transitioning to a foot abduction brace (Steenbeek / Mitchell-Ponseti brace: 23 hr/day for 3 months, then nights/naps until 4–5 years).

1. Identification:
   • Congenital Vertical Talus (CVT) / Rocker-Bottom Foot / Congenital Convex Pes Valgus.
2. Associated Conditions (Any four):
   • Chromosomal Aneuploidies: Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome).
   • Neural Tube Defects: Myelomeningocele / Spinal dysraphism.
   • Neuromuscular / Arthropathic Disorders: Arthrogryposis multiplex congenita, Congenital Myotonic Dystrophy.
   • Connective Tissue / Genetic Syndromes: CDG syndromes (Congenital Disorders of Glycosylation), Marfan syndrome, Neurofibromatosis Type 1.
3. Diagnostic Radiographic Feature:
   • Forced Plantarflexion Lateral Radiograph:
     • Demonstrates fixed vertical orientation of the talus along the longitudinal axis of the tibia (talocalcaneal divergence).
     • Irreducible dorsal dislocation of the navicular on the talar head: The longitudinal axis of the talus (talar centerline) fails to align with the longitudinal axis of the first metatarsal on maximal plantarflexion (in a flexible calcaneovalgus foot, the talometatarsal line aligns in plantarflexion).
     • The calcaneus remains in equinus (tilted downwards) with an increased talocalcaneal angle.
4. Management Protocol (Dobbs Method):
   • Serial Manipulation and Casting ("Reverse Ponseti" Technique):
     • Serial weekly long-leg plaster casts applied with the knee flexed at $90^\circ$.
     • Manipulation applies continuous counter-pressure over the medial aspect of the talar head (sustentaculum tali) while adducting, plantarflexing, and inverting the forefoot to stretch contracted dorsolateral structures and relocate the dislocated talonavicular joint.
   • Operative Realignment Step:
     • Percutaneous/minimal-access reduction and fixation of the talonavicular joint with a Kirschner wire (K-wire).
     • Concomitant percutaneous Achilles tenotomy to relieve fixed hindfoot equinus.
     • K-wire is removed after 5–6 weeks, followed by dynamic foot abduction bracing until 2–3 years of age.

1. Diagnosis and Embryology:
   • Diagnosis: Cervical Cystic Hygroma / Macrocystic Lymphatic Malformation of the neck.
   • Embryologic Mechanism: Failure of the primitive pair of jugular lymphatic sacs to establish normal communication and drainage into the internal jugular venous system (internal jugular vein) during the 6th to 8th weeks of embryonic gestation, resulting in progressive sequestration, lymphatic fluid accumulation, and endothelial-lined macrocystic dilatation.
2. Associated Syndromes:
   • Turner syndrome (45,X — classically associated with posterior nuchal cystic hygroma).
   • Down syndrome (Trisomy 21).
   • Noonan syndrome.
   • Trisomy 18 (Edwards syndrome) or Trisomy 13 (Patau syndrome).
3. Most Common Anatomical Sites:
   • Cervical / Neck: Posterior triangle of the neck (approximately 75–80% of cases).
   • Axilla: Axillary region (15–20% of cases).
   • Mediastinum / Retroperitoneum: Thoracic cavity and abdominal retroperitoneal space (3–5%).
   • Groin / Pelvis: Inguinal, gluteal, or pelvic regions (1–2%).
4. Management and Risks:
   • Intralesional Sclerotherapy (First-line for Macrocystic Lesions $>1\text{ cm}$):
     • Bleomycin: Antineoplastic glycopeptide antibiotic that causes localized endothelial cell damage, fibrosis, and cavity obliteration without extensive surrounding inflammation.
     • OK-432 (Picibanil): Lyophilized mixture of low-virulence Streptococcus pyogenes treated with penicillin; induces marked neutrophil/macrophage recruitment, cytokine release (IL-1, IL-2, TNF-$\alpha$), endothelial necrosis, and sclerosis.
     • Alternatives: Doxycycline, Polidocanol, Sirolimus (oral mTOR inhibitor for refractory/microcystic forms).
   • Surgical Excision: Complete microsurgical resection indicated if sclerotherapy fails, if there is acute airway/esophageal compromise, or for well-circumscribed cosmetic lesions.
   • Critical Nerves at Risk During Cervical Resection:
     • Spinal Accessory Nerve (CN XI) in the posterior triangle (risk of trapezius paralysis/shoulder drop).
     • Facial Nerve marginal mandibular branch (risk of lower lip asymmetry).
     • Hypoglossal Nerve (CN XII) / Phrenic Nerve / Recurrent Laryngeal Nerve / Vagus Nerve.

1. Clinical Signs & Neonatal Maneuvers:
   • Galeazzi sign (Allis sign): Apparent shortening of the femur manifested as lower knee height on the affected side when both hips and knees are flexed to 90° with feet flat on the examining table.
   • Barlow test: Provocative test of instability; attempts to dislocate a seated femoral head posteriorly out of the acetabulum (flexion and adduction with posterior axial thrust).
   • Ortolani test: Reduction test; reduces a dislocated femoral head back into the acetabulum with a palpable "clunk" (flexion and gentle abduction with anterior lift on the greater trochanter).
2. Major Risk Factors:
   • Female sex (female-to-male ratio approximately 5:1 to 8:1 due to maternal relaxin sensitivity).
   • Breech presentation (especially frank breech).
   • Primiparity (tight maternal abdominal and uterine musculature).
   • Positive family history of developmental dysplasia of the hip (first-degree relative).
   • Oligohydramnios.
3. Associated Intrauterine Packaging Defects:
   • Congenital muscular torticollis (CMT).
   • Congenital talipes equinovarus (CTEV) or metatarsus adductus.
4. Radiographic Assessment and Orthotic Intervention:
   • Radiographic Reference Lines (AP Pelvis):
     • Hilgenreiner line: Horizontal line connecting both triradiate cartilages.
     • Perkin line: Vertical line perpendicular to Hilgenreiner line, drawn through the superolateral margin of the acetabular roof.
     • Normal localization: The femoral head ossification center or medial femoral neck should lie in the inferomedial quadrant.
     • Shenton line: Continuous smooth arc formed by the medial border of the femoral neck and superior border of the obturator foramen (broken in subluxation/dislocation).
     • Acetabular Index: Angle formed between Hilgenreiner line and a line tangent to the acetabular roof (normally $<30^\circ$ at birth, $<25^\circ$ by 6 months).
   • Primary Intervention: Dynamic flexion-abduction splinting using a Pavlik harness (maintaining $90^\circ\text{--}100^\circ$ hip flexion and $45^\circ\text{--}60^\circ$ controlled abduction; avoiding extreme hyperabduction to prevent avascular necrosis of the femoral head).

1. Radiological Findings:
   • Sagittal clefting/bifurcation of the spinal cord into two separate hemicords (diplomyelia/split cord).
   • An intervening central osseous or fibrocartilaginous spur/septum originating from the posterior vertebral body and traversing the spinal canal.
2. Definitive Diagnosis & Classification:
   • Diagnosis: Split Cord Malformation (SCM) / Diastematomyelia.
   • Pang Classification:
     • Type I SCM: Two distinct hemicords, each contained within its own individual dural sac, separated by a rigid osseocartilaginous spur.
     • Type II SCM: Two hemicords contained within a single shared dural sac, separated by a non-rigid, thin fibrous septum.
3. Cutaneous Markers of Occult Spinal Dysraphism:
   • Localized hypertrichosis ("faun tail" hair patch).
   • Midline lumbar or sacral subcutaneous lipoma.
   • Congenital dermal sinus tract or deep midline dimple (above the gluteal crease, $>5\text{ mm}$ depth or $>2.5\text{ cm}$ from anal verge).
   • Atypical cutaneous vascular malformation (capillary hemangioma/port-wine stain over the midline spine).
   • Rudimentary caudal appendage (human tail) or skin tag.
4. Definitive Surgical Management:
   • Operative Strategy: Laminectomy, microsurgical excision/resection of the osseocartilaginous or fibrous spur, division of any associated tethering bands/tight filum terminale, and reconstruction of a single dural tube (for Type I).
   • Primary Goal: Complete detethering of the neural elements to arrest progressive neurological, urological, and orthopedic deformities.

1. Imaging Modality & Radiopharmaceuticals:
   • Modality: Diuretic Renography (Dynamic Renal Scintigraphy).
   • Radiotracers:
     • Technetium-99m L,L-ethylenedicysteine ($^{99\text{m}}\text{Tc}$-EC).
     • Technetium-99m mercaptoacetyltriglycine ($^{99\text{m}}\text{Tc}$-MAG3).
2. Diuretic Drainage Kinetics ($T_{1/2}$ Clearance Parameters):
   • Normal / Non-obstructed: $T_{1/2} < 10\text{ minutes}$ (rapid washout after furosemide challenge).
   • Equivocal / Indeterminate: $T_{1/2} = 10\text{ to } 20\text{ minutes}$.
   • Obstructed System: $T_{1/2} > 20\text{ minutes}$ with a persistently rising or plateaued accumulation renogram curve showing no response to furosemide.
3. Indications for Surgical Intervention in PUJO:
   • Impaired differential (split) renal function of the affected kidney ($<40\%$ on renogram).
   • Documented progressive decline in split renal function ($>5\text{--}10\%$ on serial functional studies).
   • Progressive increase in anteroposterior pelvic diameter ($>20\text{--}30\text{ mm}$) or worsening calyceal dilatation with parenchymal thinning on serial ultrasound.
   • Breakthrough febrile urinary tract infections despite antibiotic prophylaxis, or recurrent flank pain/palpable abdominal mass.
4. Definitive Surgical Procedure:
   • Anderson-Hynes dismembered pyeloplasty (open, laparoscopic, or robot-assisted).

1. Diagnosis & Differential Diagnoses:
   • Most Probable Diagnosis: Biliary Atresia (Extrahepatic Biliary Atresia - EHBA).
   • Differential Diagnoses:
     • Idiopathic neonatal giant-cell hepatitis.
     • Alpha-1 antitrypsin deficiency (PiZZ phenotype).
     • Alagille syndrome (arteriohepatic dysplasia).
     • Progressive familial intrahepatic cholestasis (PFIC).
     • Congenital infections (TORCH / CMV, toxoplasmosis, syphilis).
     • Choledochal cyst (causing obstructive jaundice).
2. Sonographic Signs of Biliary Atresia:
   • Triangular cord sign: Triangular or tubular echogenic fibrous tissue thick band anterior to the portal vein bifurcation ($>3.5\text{ mm}$ thickness).
   • Gallbladder abnormalities: Small/hypoplastic ($<1.5\text{ cm}$), absent, or non-contractile gallbladder with irregular/echogenic mucosal lining (gallbladder ghost triad).
3. Gold-Standard Diagnostic Modality:
   • Intraoperative Cholangiography (IOC): Confirms complete obstruction, atresia, or discontinuity of the extrahepatic biliary system.
4. Surgical Management & Prognosis:
   • Procedure of Choice: Kasai hepatoportoenterostomy (resection of the fibrous biliary plate with reconstruction via a Roux-en-Y jejunal loop anastomosis).
   • Optimal Age Window: Best performed before 60 days of life (drainage rates $>70\text{--}80\%$; success decreases significantly after 60–90 days due to irreversible intrahepatic fibrosis).
   • Definitive Salvage Therapy: Orthotopic Liver Transplantation (indicated in primary Kasai failure, progressive secondary biliary cirrhosis, or recurrent intractable cholangitis with portal hypertension).

1. Vertebral Anomaly & Embryological Basis:
   • Anomaly: Hemivertebra.
   • Embryological Mechanism: Failure of formation (unilateral complete or partial failure of development of a chondrification center of the primitive vertebral body during blastemic and chondrification phases of somite embryogenesis).
2. Anatomical Classification (Segmentation Status):
   • Fully segmented (free) hemivertebra: Normal intervertebral disc spaces present both above and below the hemivertebra; possesses normal growth plates on both superior and inferior surfaces (highest risk of progressive curvature).
   • Semi-segmented hemivertebra: Fused to an adjacent vertebral body on one side with an open, functioning growth plate and disc on the other side.
   • Unsegmented (fused) hemivertebra: Continuous with adjacent vertebral bodies both above and below with no intervening disc space; poor growth potential (lowest risk of progressive scoliosis).
   • Incarcerated hemivertebra: The anomalous half-vertebra is accommodated into a complementary recess within adjacent normal-sized vertebrae, minimizing overall spinal curve progression.
3. Incidence & Spinal Deformities:
   • Estimated Incidence: Approximately 1 in 1,000 to 1 in 3,000 live births.
   • Secondary Structural Spinal Deformities:
     • Congenital scoliosis (coronal plane deformity).
     • Congenital kyphosis or kyphoscoliosis (sagittal/combined plane deformity, carrying high risk of paraplegia if posterior failure of formation exists).
4. Systemic Screening Protocol (VACTERL Association Screening):
   • Renal: Ultrasonography of kidneys, ureters, and bladder to rule out unilateral renal agenesis, horseshoe kidney, multicystic dysplastic kidney, or ectopia (present in up to 30% of congenital scoliosis).
   • Cardiac: Transthoracic echocardiogram (ECHO) to rule out ventricular septal defect, atrial septal defect, tetralogy of Fallot, or coarctation of aorta.
   • Spinal Axis: Whole-spine Magnetic Resonance Imaging (MRI) to detect associated intraspinal abnormalities (tethered cord, syringomyelia, split cord malformation/diastematomyelia, low-lying conus medullaris).
   • Gastrointestinal & Anorectal: Clinical and radiographic assessment to rule out anorectal malformations (imperforate anus) and tracheoesophageal fistula/esophageal atresia.
   • Limb: Radiographs of upper and lower limbs to exclude radial ray anomalies, hypoplasia/absence of radius or thumb, and polydactyly/syndactyly.

1. Diagnosis and Genetics:
   • Diagnosis: Hereditary Multiple Exostoses (HME) / Hereditary Multiple Osteochondromas (HMO) / Diaphyseal Aclasis.
   • Inheritance: Autosomal dominant with high penetrance (~95-100%).
   • Genetic etiology: Loss-of-function mutations in EXT1 (chromosome 8q24.11) or EXT2 (chromosome 11p11.2), which encode exostosin glycosyltransferases responsible for heparan sulfate proteoglycan biosynthesis.
2. Radiological Features:
   • Sessile or pedunculated bony outgrowths arising from the metaphysis of long bones, projecting away from the adjacent growth plate/joint.
   • Direct continuity of the cortical bone and medullary cavity of the exostosis with the cortex and medullary cavity of the host bone (pathognomonic).
   • Metaphyseal widening or flaring ("trumpeting" of metaphyses).
   • Cartilaginous cap that may show irregular stippled or punctate calcifications.
3. Clinical & Skeletal Complications:
   • Limb length discrepancy and short stature.
   • Forearm deformity (pseudo-Madelung deformity due to disproportionate shortening of the ulna, secondary radial bowing, and radial head dislocation).
   • Angular lower-extremity deformities (genu valgum, ankle valgus).
   • Neurovascular impingement (e.g., common peroneal nerve palsy, popliteal vessel compression, or pseudoaneurysm formation).
   • Adventitious bursitis or snapping tendons over prominent bony lesions.
4. Malignant Transformation:
   • Malignancy: Secondary chondrosarcoma (arising from the cartilaginous cap).
   • Lifetime risk: Approximately 1% to 5%.
   • Clinical/radiological red flags:
     • Rapid enlargement of a preexisting lesion after skeletal maturity.
     • New-onset, persistent, localized pain or nocturnal pain in a previously asymptomatic lesion.
     • Cartilage cap thickness $>1.5\text{ to }2.0\text{ cm}$ on MRI in skeletally mature adolescents/adults.
     • Cortical destruction, bone erosion, or adjacent soft-tissue mass.

1. Clinical Finding and Diagnosis:
   • Clinical sign: Meconuria (passage of meconium per urethra).
   • Anatomical communication: Rectourinary fistula (most commonly rectoprostatic urethral fistula or rectobladder-neck fistula).
   • Classification: High Anorectal Malformation (ARM) in a male.
2. Invertogram Assessment:
   • Historical investigation: Wangenstein-Rice Invertogram (upside-down lateral view).
   • Timing: Must be performed after 18 to 24 hours of life (to allow swallowed air to traverse the intestinal tract, overcome rectal pouch smooth-muscle tone, and reach the terminal distal blind pouch).
   • Radiological determination:
     • Pubococcygeal line (PC line): Drawn from the superior border of the pubic symphysis to the sacrococcygeal junction.
     • Ischial point (I-point): Inferior margin of the ischial tuberosity.
     • High ARM: Distal rectal gas bubble terminates above the PC line.
     • Intermediate ARM: Gas bubble terminates between the PC line and the I-point.
     • Low ARM: Gas bubble extends below the I-point.
3. Modern Imaging & Screening:
   • Imaging: Cross-table lateral prone or lateral decubitus shoot-through radiograph (prone cross-table lateral film with hips elevated on a bolster) and high-resolution perineal ultrasound.
   • Screening mnemonic: VACTERL association:
     • V: Vertebral anomalies (sacral radiography, spinal USG/MRI).
     • A: Anal atresia.
     • C: Cardiac defects (echocardiography).
     • T-E: Tracheoesophageal fistula with esophageal atresia (passage of nasogastric tube).
     • R: Renal and urinary tract anomalies (abdominal/renal USG).
     • L: Limb anomalies (radial ray defects, hypoplastic thumbs).
4. Management Strategy:
   • Neonatal stabilization: Keep nil per os (NPO), placement of a decompressive orogastric tube, intravenous fluid maintenance, and broad-spectrum intravenous antibiotics.
   • Urological care: Insert a soft urethral catheter to maintain bladder decompression and urine output monitoring.
   • Surgical procedure: Primary single-stage repair in the newborn period is contraindicated in high ARM with a rectourethral fistula. The infant requires an immediate high divided sigmoid colostomy (with completely separated proximal and distal stomas to prevent fecal spillover and recurrent urinary sepsis). Definitive repair with Posterior Sagittal Anorectoplasty (PSARP / Peña procedure) is performed electively at 2 to 6 months of age.

1. Radiological Finding & Diagnosis:
   • Radiograph finding: Massive, diffuse subperiosteal new bone formation causing progressive cortical thickening (hyperostosis) restricted to the diaphysis of the bone, with complete preservation of the epiphyses and metaphyses.
   • Diagnosis: Infantile Cortical Hyperostosis (Caffey Disease).
2. Skeletal Distribution:
   • Most commonly involved bone: Mandible (involved in 75% to 90% of cases).
   • Characteristically spared bones: Phalanges and vertebral bodies.
3. Genetic Mutation:
   • Heterozygous missense mutation in the COL1A1 gene (specifically c.3040C>T, p.Arg1014Cys) on chromosome 17q21.33, encoding the $\alpha 1$ chain of type I collagen.
4. Differential Diagnoses:
   • Prolonged prostaglandin infusion ($PGE_1$ or $PGE_2$ used in ductal-dependent congenital heart disease).
   • Chronic hypervitaminosis A.
   • Acute osteomyelitis / septic arthritis.
   • Congenital syphilis (syphilitic periostitis).
   • Non-accidental trauma / child physical abuse (multiple healing fractures with subperiosteal hematoma).
   • Congenital rickets or healing scurvy.
   • Primary bone malignancy (Ewing sarcoma) or metastatic neuroblastoma.
5. Treatment and Natural History:
   • First-line medical therapy: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation:
     • Indomethacin: 1.5 to 2.5 mg/kg/day PO divided every 8 to 12 hours, OR
     • Ibuprofen: 10 mg/kg/dose PO every 8 hours.
   • Severe or refractory disease (systemic toxicity or airway compromise from mandibular swelling):
     • Oral Prednisolone: 1 to 2 mg/kg/day tapered over 2 to 4 weeks, or IV Methylprednisolone pulse.
   • Natural history: Benign and self-limiting; active inflammatory flare-ups generally resolve spontaneously within 6 to 12 months with complete radiographic bone remodeling over several years.

1. Diagnosis & Histopathology:
   • Diagnosis: Kasabach-Merritt Phenomenon (KMP) / Kasabach-Merritt Syndrome.
   • Underlying vascular tumors: Kaposiform Hemangioendothelioma (KHE) or Tufted Angioma (TA). (Note: Common infantile hemangioma does not cause true Kasabach-Merritt phenomenon).
2. Pathophysiology:
   • Abnormal, slit-like, convoluted, dysplastic neoplastic vascular channels within the tumor cause turbulent blood flow and expose abnormal subendothelial matrix.
   • Platelets undergo massive intralesional trapping, aggregation, and consumption within the tumor bed.
   • Trapped activated platelets trigger sustained activation of the coagulation cascade, leading to severe consumptive coagulopathy characterized by hypofibrinogenemia and secondary hyperfibrinolysis (marked D-dimer elevation).
   • Entangled erythrocytes experience high-shear mechanical fragmentation across intralesional microthrombi, resulting in microangiopathic hemolytic anemia (schistocytes on blood film).
3. First-Line Pharmacological Regimen:
   • Dual therapy combining an mTOR inhibitor and systemic corticosteroids:
     • Sirolimus (Rapamycin):
       • Starting dose: $0.8\text{ mg/m}^2/\text{dose}$ PO twice daily (or approximately $0.05\text{ to }0.1\text{ mg/kg/day}$).
       • Target therapeutic serum trough level: 8 to 15 ng/mL.
     • Systemic Corticosteroid:
       • Intravenous Methylprednisolone: $2\text{ mg/kg/day}$ IV in divided doses, OR
       • Oral Prednisolone: $2\text{ to }3\text{ mg/kg/day}$ PO.
     • Second-line / bridge agent: Intravenous Vincristine: $0.05\text{ mg/kg}$ IV once weekly (for infants $<10\text{ kg}$) or $1.5\text{ mg/m}^2$ IV once weekly.
4. Platelet Transfusion Recommendation:
   • Routine or prophylactic platelet transfusions are strictly contraindicated.
   • Transfused platelets are immediately trapped within the abnormal tumor channels ("fueling the fire"), causing acute tumor enlargement, increased pain, worsening consumptive coagulopathy, and secondary thrombosis.
   • Platelet transfusions are restricted exclusively to active, life-threatening internal hemorrhage or immediate preparation for urgent, life-saving surgical intervention.

1. Diagnosis & Classic Triad:
   • Diagnosis: Klippel-Feil Syndrome (Congenital Brevicollis / Congenital Cervical Vertebral Synostosis).
   • Classic Clinical Triad:
     • Short neck.
     • Low posterior hairline.
     • Marked limitation / restriction of cervical spine motion.
       (Note: The complete triad is present in less than 50% of affected individuals).
2. Radiological Hallmark:
   • Congenital fusion (failure of normal embryonic somite segmentation) of two or more cervical vertebrae (most commonly C2-C3 or C5-C6), with decreased intervertebral disc spaces, flattened vertebral bodies, and narrowing of the spinal canal.
3. Associated Systemic Anomalies (Mandatory Screening):
   • Renal anomalies: Unilateral renal agenesis, horseshoe kidney, or hydronephrosis in 30% to 40% (screen via abdominal/renal ultrasound).
   • Sensorineural or conductive hearing loss in ~30% (screen via comprehensive audiometry).
   • Congenital heart defects: Ventricular septal defect (VSD), atrial septal defect (ASD), or patent ductus arteriosus (PDA) in 10% to

1. Radiological Abnormalities:
   • Increased radiodensity (sclerosis) of the capital femoral epiphysis.
   • Flattening, loss of height, and collapse of the femoral capital epiphysis (coxa plana).
   • Subchondral fracture line appearing as a crescent-shaped radiolucency (Caffey's crescent sign).
   • Fragmentation of the femoral head with widening of the medial joint space (Waldenström sign) and secondary femoral neck widening (coxa magna).
2. Diagnosis & Pathophysiology:
   • Diagnosis: Legg-Calvé-Perthes Disease (LCPD; Coxa Plana).
   • Pathophysiology: Idiopathic, episodic interruption of the arterial blood supply (primarily via the lateral epiphyseal branches of the medial femoral circumflex artery) to the growing capital femoral epiphysis, resulting in osteonecrosis (avascular necrosis), followed by creeping substitution, revascularization, resorption, and bone remodeling.
3. Waldenström Classification Stages:
   • Stage I (Initial / Necrosis): Sclerosis, cessation of epiphyseal growth, widening of the articular cartilage space, and subchondral radiolucent fracture line (Crescent sign).
   • Stage II (Fragmentation): Resorption of necrotic bone with radiolucent areas alternating with dense bone; collapse and lateral extrusion of the epiphysis.
   • Stage III (Reossification / Healing): New immature bone trabeculae form at the margins and advance centrally into the epiphysis; reconstitution of the femoral head contour.
   • Stage IV (Healed / Residual deformity): Complete replacement by mature trabecular bone with permanent residual alterations in sphericity and congruency (e.g., coxa plana, coxa magna, coxa breva).
4. Catterall "Head-at-Risk" Signs & Containment Indications:
   • Gage's Sign: A small V-shaped osteolytic radiolucency on the lateral aspect of the epiphysis and adjacent metaphysis.
   • Lateral Subluxation / Extrusion: Lateral displacement of the femoral head beyond the lateral acetabular margin (extrusion index $>20\%$).
   • Calcification Lateral to Epiphysis: Calcific deposits appearing lateral to the capital ossification center.
   • Diffuse Metaphyseal Reaction: Transverse metaphyseal radiolucent bands or broad lucency.
   • Horizontal Growth Plate: Horizontal orientation of the physis.
   • Surgical Indications: Age at presentation $\ge 6$ years, progressive femoral head extrusion ($>20\%$ uncovered), Catterall Group III or IV, or Herring lateral pillar group B or B/C border, to achieve femoral head containment via varus derotation osteotomy (VDRO) or Salter innominate pelvic osteotomy.

1. Age at onset: Children $<6$ years have substantial remodeling potential and favorable long-term outcomes; children $\ge 8$ years carry an elevated risk of premature degenerative osteoarthritis.
2. Herring Lateral Pillar Classification:
   • Group A: No loss of height in the lateral pillar ($100\%$ height maintained); excellent prognosis.
   • Group B: Height loss $<50\%$ of the lateral pillar; favorable outcome if $<8$ years old.
   • Group B/C: Borderline loss of lateral pillar; containment improves congruency.
   • Group C: Height loss $>50\%$ of the lateral pillar; poor prognosis regardless of treatment.

1. Clinical Tests of Arachnodactyly:
   • Walker-Murdoch Sign (Wrist Sign): Positive when the distal phalanx of the thumb and the fifth digit overlap when encircling the contralateral wrist.
   • Steinberg Sign (Thumb Sign): Positive when the entire distal phalanx of the adducted thumb projects beyond the ulnar border of the hand when folded inside a clenched fist.
2. Etiology and Ocular Manifestation:
   • Genetic Defect: Pathogenic mutation in the FBN1 gene on chromosome 15q21.1 encoding Fibrillin-1.
   • Inheritance: Autosomal Dominant (75% inherited, 25% de novo mutations).
   • Ocular Feature: Ectopia lentis (subluxation of the crystalline lens, characteristically bilateral, superior, and temporal).
3. Anthropometric Calculations:
   $$ > \begin{aligned} > \text{Upper Segment (US)} &= \text{Total Height} - \text{Lower Segment} \\ > &= 172\text{ cm} - 96\text{ cm} = \mathbf{76\text{ cm}} \\ > \text{US:LS Ratio} &= \frac{76\text{ cm}}{96\text{ cm}} = \mathbf{0.79} \quad (\text{Normal for } \ge 10\text{ yr: } \ge 0.90 \text{ to } 1.0) \\ > \text{Arm Span : Height Ratio} &= \frac{184\text{ cm}}{172\text{ cm}} = \mathbf{1.07} \quad (\text{Normal: } \le 1.05) > \end{aligned} > $$
   • Interpretation: A reduced US:LS ratio ($<0.86$) and an elevated arm-span-to-height ratio ($>1.05$) demonstrate significant disproportionate dolichostenomelia.
4. Diagnostic Criteria (Revised Ghent Nosology - No Family History):
   • Diagnosis is confirmed if any of the following 4 criteria combinations are met:
     • Aortic root dilatation ($Z\text{-score} \ge 2.0$) AND Ectopia lentis.
     • Aortic root dilatation ($Z\text{-score} \ge 2.0$) AND documented causal FBN1 mutation.
     • Aortic root dilatation ($Z\text{-score} \ge 2.0$) AND Systemic score $\ge 7$ points.
     • Ectopia lentis AND an FBN1 mutation previously linked to aortic enlargement.
5. Pharmacotherapy & Surveillance:
   • First-Line Agents:
     • Beta-adrenergic antagonists (e.g., Atenolol $1\text{ to }2\text{ mg/kg/day}$ once daily or Propranolol $1\text{ to }3\text{ mg/kg/day}$ divided BID/TID) titrated to reduce resting heart rate to $<60\text{--}70\text{ bpm}$ and blunt the aortic hemodynamic pulse wave ($\mathrm{dP/dt}$).
     • Angiotensin II Receptor Blockers (ARBs) (e.g., Losartan $0.7\text{ to }1.4\text{ mg/kg/day}$ once daily, max $100\text{ mg/day}$) to selectively block TGF-$\beta$ signaling and inhibit aortic matrix remodeling.
   • Echocardiographic Surveillance: Annual transthoracic echocardiography to track aortic root diameter and calculate aortic root $Z$-scores; increased to every 6 months if aortic root diameter approaches $4.5\text{ cm}$, rapid expansion occurs ($>0.5\text{ cm/year}$), or $Z$-score $>3.0$.

1. Diagnosis & Gold-Standard Modality:
   • Diagnosis: Intestinal Malrotation with secondary intermittent Midgut Volvulus.
   • Gold-Standard Imaging Modality: Upper Gastrointestinal (UGI) Contrast Study (Barium / Water-soluble Upper GI series).
2. Characteristic Fluoroscopic Findings:
   • Abnormal position of the duodenojejunal (DJ) flexure: fails to cross the midline to the left of the left vertebral pedicle and lies inferior to the level of the duodenal bulb (L1–L2).
   • "Corkscrew" or spiral configuration of the distal duodenum and proximal jejunum indicative of midgut volvulus.
   • Duodenal obstruction with proximal dilatation (duodenal "beaking" or bird-beak tapering at the third part of the duodenum) caused by extrinsic compression from Ladd bands.
3. Operative Procedure & Sequential Steps:
   • Procedure: Ladd Procedure (performed open or laparoscopically).
   • Sequential Steps:
     • Step 1: Evisceration and Counter-Clockwise Detorsion: Exteriorize the bowel and untwist the midgut volvulus in a counter-clockwise direction.
     • Step 2: Division of Ladd Bands: Divide the congenital peritoneal bands traversing the duodenum from the cecum and right colon to the posterior abdominal wall to relieve duodenal obstruction.
     • Step 3: Widening of the Mesenteric Base: Mobilize the duodenum and separate the mesenteric attachments between the duodenum and colon to broaden the base of the small-bowel mesentery and prevent recurrent torsion.
     • Step 4: Appendectomy & Non-Rotated Repositioning: Perform an incidental appendectomy (to prevent future diagnostic dilemmas from left-sided appendicitis) and place the gut in the position of non-rotation (entire small intestine placed into the right hemiabdomen, and cecum/colon placed into the left hemiabdomen).
4. Fluid Requirement Calculation (Weight = 18 kg, 5% Deficit):
   $$ > \begin{aligned} > \text{Maintenance Volume (Holliday-Segar)} &= (10\text{ kg} \times 100\text{ mL}) + (8\text{ kg} \times 50\text{ mL}) \\ > &= 1000\text{ mL} + 400\text{ mL} = \mathbf{1400\text{ mL/day}} \\ > \text{Deficit Volume (5\% of 18 kg)} &= 5\% \times 18\text{ kg} \times 1000\text{ mL/kg} \\ > &= 0.05 \times 18000\text{ mL} = \mathbf{900\text{ mL}} \\ > \text{Total 24-Hour Fluid Volume} &= \text{Maintenance} + \text{Deficit} \\ > &= 1400\text{ mL} + 900\text{ mL} = \mathbf{2300\text{ mL}} > \end{aligned} > $$
   • Fluid Delivery: Administer initial bolus of $20\text{ mL/kg}$ ($360\text{ mL}$) of Isotonic Crystalloid ($0.9\%$ Normal Saline or Ringer's Lactate) if hypoperfused; remaining fluid administered as $0.9\%$ Normal Saline in $5\%$ Dextrose with $20\text{ mEq/L}$ KCl over 24 hours (giving half the deficit in the first 8 hours, and the remainder over the next 16 hours).

1. Diagnosis & Pathophysiology:
   • Diagnosis: Neonatal Ovarian Cyst (NOC).
   • Pathophysiology: Hyperstimulation of the fetal/neonatal ovarian follicles mediated by high circulating concentrations of maternal estrogens, placental human chorionic gonadotropin (hCG), and endogenous fetal pituitary gonadotropins (FSH and LH). After delivery, the abrupt withdrawal of maternal and placental hormones leads to spontaneous involution in most cases.
2. Sonographic Classification:
   • Simple Cyst: Anechoic, round or oval, thin-walled ($<2\text{ mm}$), unilocular, completely devoid of internal echoes, with posterior acoustic enhancement.
   • Complex / Complicated Cyst: Thickened or irregular walls, internal fluid-debris levels, retracting clot, heterogeneous internal echoes, septations, calcifications, or the "wandering cyst" sign, pathognomonic of secondary adnexal torsion or intra-cystic hemorrhage.
3. Dimensional Cutoff:
   • Cysts $<2\text{ cm}$ in diameter are considered physiologic follicles.
   • Lesions $\mathbf{\ge 2\text{ cm}}$ (specifically $\ge 4\text{ to }5\text{ cm}$) are classified as pathological neonatal ovarian cysts carrying elevated risk for torsion and require formal postnatal serial ultrasound surveillance.
4. Catastrophic Complications:
   • Ovarian torsion with hemorrhagic infarction and autoamputation (resulting in a wandering peritoneal mass and loss of the ovary).
   • Intra-cystic hemorrhage leading to rupture, hemoperitoneum, and hypovolemic shock.
   • Extrinsic mechanical compression resulting in intestinal obstruction or urinary tract compression (hydronephrosis).
5. Management Algorithm:
   • Asymptomatic Simple Cysts $<4\text{ to }5\text{ cm}$: Conservative observation with serial ultrasonography every 4 to 6 weeks; high rate of spontaneous regression within 3 to 6 months.
   • Asymptomatic Simple Cysts $\ge 4\text{ to }5\text{ cm}$: Ultrasound-guided percutaneous percutaneous needle aspiration under aseptic conditions to decompress the cyst and prevent torsion, while preserving ovarian parenchyma.
   • Complex / Symptomatic / Torsed Cysts (any size) or Persistently Enlarging Cysts: Surgical intervention via minilaparotomy or laparoscopy. The preferred procedure is ovarian-preserving cystectomy (or de-torsion and cystectomy); salpingo-oophorectomy is reserved solely for entirely necrotic, gangrenous tissue.

1. Diagnosis & Radiographic Features:
   • Diagnosis: Active Nutritional Vitamin D Deficiency Rickets.
   • Radiographic Features:
     • Widening: Increased thickness/height of the radiolucent physeal growth plate due to accumulation of unmineralized osteoid.
     • Cupping: Concavity of the metaphysis facing the epiphysis.
     • Fraying: Indistinct, brush-like, irregular margins of the metaphysis due to disorganized trabeculae.
     • Splaying: Flaring and lateral expansion of the distal metaphyseal margin.
2. Earliest Clinical & Healing Radiographic Signs:
   • Earliest Clinical Sign: Craniotabes (ping-pong ball-like softening and compressibility of the parietal and occipital skull bones, detectable as early as 1 to 3 months of life).
   • First Radiographic Sign of Healing: Reappearance of the provisional zone of calcification, seen as a dense, transverse, chalky white line crossing the metaphyseal margin separate from the shaft, occurring within 1 to 3 weeks of therapy.
3. Biochemical Profile:
   • Serum Calcium: Low or normal (maintained by secondary hyperparathyroidism).
   • Serum Inorganic Phosphate: Low ($<3.0\text{ mg/dL}$ or $<0.97\text{ mmol/L}$) due to PTH-mediated renal phosphaturia.
   • Alkaline Phosphatase (ALP): Markedly elevated (often $>800\text{--}2000\text{ IU/L}$), representing osteoblast hyperactivity.
   • Serum 25-hydroxyvitamin D [25(OH)D]: Severely deficient ($<10\text{--}12\text{ ng/mL}$ or $<25\text{--}30\text{ nmol/L}$).
   • Serum Intact Parathyroid Hormone (iPTH): Markedly elevated (secondary hyperparathyroidism).
4. Therapeutic Protocol & Prophylaxis:
   • Vitamin D Therapy (Cholecalciferol):
     • Daily Regimen: Cholecalciferol $2,000\text{ IU (50 }\mu\text{g)}$ orally once daily for a duration of 12 weeks (3 months); OR
     • Single-Day Stoss Therapy: Cholecalciferol $100,000\text{ to }300,000\text{ IU}$ orally administered in 1 to 2 divided doses over a single day (indicated where compliance is questionable; avoid in children $<3$ months).
   • Elemental Calcium Co-administration:
     • $30\text{ to }50\text{ mg/kg/day}$ of elemental calcium orally divided in 2 to 3 doses (e.g., Calcium carbonate or calcium glubionate) for the first 2 to 4 weeks of treatment to avert the "hungry bone syndrome" (acute hypocalcemic tetany/seizures during rapid remineralization).
   • Long-Term Maintenance Prophylaxis:
     • Once the 12-week therapeutic course is complete and healing is documented, initiate maintenance prophylaxis: $400\text{ IU/day}$ orally for infants $<12$ months, or $600\text{ IU/day}$ orally for children $>12$ months.

graph TD
    A[Vitamin D Deficiency] --> B[Decreased Intestinal Ca & PO4 Absorption]
    B --> C[Transient Hypocalcemia]
    C --> D[Secondary Hyperparathyroidism: Elevated PTH]
    D --> E[Renal 1-alpha-hydroxylase Activation]
    D --> F[Renal Tubular Phosphate Wasting: Hypophosphatemia]
    D --> G[Bone Resorption: Calcium Normalizes at Expense of Skeleton]
    F --> H[Impaired Apoptosis of Late Hypertrophic Chondrocytes]
    H --> I[Failure of Mineralization of Provisional Zone]
    I --> J[Osteoid Accumulation: Splaying, Fraying, Cupping]

Radiographic monitoring should be performed 4 to 6 weeks after initiating therapy to document the appearance of the provisional line of calcification and normalization of alkaline phosphatase before reducing to maintenance dosing. Failure to heal after 12 weeks of documented compliance suggests vitamin D-dependent rickets (VDDR types 1 or 2) or hypophosphatemic rickets.

1. Diagnosis:
   • Osgood-Schlatter disease (traction apophysitis of the tibial tuberosity).
2. Pathophysiology:
   • Repetitive microtrauma and tensile traction overload exerted by the patellar tendon on the secondary ossification center (apophysis) of the tibial tubercle during adolescent rapid growth spurts.
   • Leads to micro-avulsion fractures, fibrocartilage proliferation, localized avascularity, and subsequent heterotopic or prominent ossification.
3. Radiographic Features:
   • Prominence, soft tissue swelling, and irregularity or fragmentation of the tibial tubercle ossification center.
   • Separate ossicle or free bony fragment located within the distal patellar tendon anterior to the tibial tuberosity.
4. Management Protocol:
   • Activity Modification: Temporary cessation of high-impact jumping/running activities; relative rest until acute tenderness subsides (cross-training with swimming or cycling permitted).
   • Physical Therapy: Stretching of the quadriceps and hamstring muscles; progressive isometric, concentric, and eccentric quadriceps strengthening once pain-free.
   • Pharmacotherapy: Oral Ibuprofen at $10\text{ mg/kg/dose}$ PO every 6 to 8 hours (maximum $40\text{ mg/kg/day}$ or $2400\text{ mg/day}$) with meals for 7 to 10 days during acute painful flares, combined with local ice application for 15–20 minutes post-activity.
   • Adjuncts: Patellar tendon strap (infrapatellar counterforce strap) or knee sleeve for symptom relief during sport re-entry.

1. Diagnosis:
   • Patent vitellointestinal duct (patent omphalomesenteric duct / persistent omphalomesenteric fistula).
2. Cord Clamping Precaution:
   • The umbilical cord clamp must be placed at least 5 to 7 cm away from the abdominal wall base to prevent accidental transection, crushing, or iatrogenic enterocutaneous fistula/bowel necrosis of herniated intestinal mucosa or bowel loops within the umbilical cord base.
3. Diagnostic Investigations:
   • Fistulogram / Sinogram: Fluoroscopic injection of water-soluble non-ionic contrast (e.g., Iohexol) through the umbilical opening demonstrating communication with the terminal ileum.
   • High-Resolution Ultrasonography (HRUS) of the anterior abdominal wall to track the tubular fluid-filled duct running from the umbilicus to the bowel loop.
4. Definitive Surgical Management & Embryological Origin:
   • Management: Exploratory laparotomy or trans-umbilical laparoscopically assisted exploration with wedge resection or segmental ileal resection containing the base of the duct and primary end-to-end ileo-ileal anastomosis.
   • Origin: Arises from failure of normal obliteration of the embryonic vitellointestinal (omphalomesenteric) duct, connecting the embryonic midgut to the yolk sac, at the 5th to 7th week of gestation.

1. Diagnosis:
   • Flexible pes planus (flexible flat foot).
2. Classification Subtypes:
   • Flexible flatfoot (physiologic, arch restores on non-weight bearing or toe-standing).
   • Flexible flatfoot with Achilles tendon contracture (tight heel cord limiting ankle dorsiflexion past neutral with knee extended).
   • Rigid flatfoot (fixed deformity; arch does not restore with toe-standing, often due to tarsal coalition, congenital vertical talus, or inflammatory arthritis).
3. Associated Neurological / Systemic Conditions:
   • Hereditary Motor and Sensory Neuropathies (e.g., Charcot-Marie-Tooth disease).
   • Friedreich ataxia.
   • Spinal dysraphism / tethered cord syndrome.
   • Generalized ligamentous laxity syndromes (e.g., Marfan syndrome, Ehlers-Danlos syndrome, Down syndrome).
4. Conservative Management:
   • Footwear and Orthoses: Supportive footwear with a firm heel counter and medial longitudinal arch support (prefabricated semi-rigid orthotic inserts or custom orthoses with medial posting).
   • Physical Therapy: Stretching of the triceps surae (gastrocnemius-soleus complex) and Achilles tendon; intrinsic foot muscle strengthening exercises (e.g., towel scrunches, marble pick-ups).
   • Weight Management: Nutritional counseling and weight control to decrease mechanical load if overweight.
   • Symptomatic Analgesia: Short-course oral NSAIDs (e.g., Ibuprofen $10\text{ mg/kg/dose}$ PO every 8 hours) during acute pain exacerbations.

1. Diagnosis:
   • Slipped Capital Femoral Epiphysis (SCFE / Slipped Upper Femoral Epiphysis - SUFE) secondary to severe primary juvenile hypothyroidism.
2. Radiographic Evaluation:
   • Best / Most Sensitive View: Frog-leg lateral (Lauenstein) view of the pelvis and bilateral hips.
   • Radiological Line/Sign: Klein's line. A line drawn along the superior/lateral border of the femoral neck normally intersects the lateral aspect of the femoral head epiphysis; failure to intersect the epiphysis indicates posterior/inferior slippage (Trethowan's sign).
3. Biomechanical Mechanism:
   • Thyroid hormone is essential for chondrocyte maturation, terminal differentiation, and matrix mineralization in the physeal growth plate.
   • In hypothyroidism, delayed endochondral ossification leads to widening and disorganization of the hypertrophic zone of the physis, markedly reducing its shear strength against mechanical shear forces exacerbated by pubertal weight gain.
4. Management:
   • Orthopedic (Urgent): Immediate non-weight-bearing (strict bed rest, wheelchair/crutches); urgent single-screw in situ percutaneous cannulated screw fixation across the physis to prevent further slippage, avascular necrosis, and chondrolysis. Prophylactic pinning of the contralateral unaffected hip is strongly indicated due to high bilateral risk in endocrine-associated SCFE.
   • Endocrine Therapy: Oral Levothyroxine replacement started at $2\text{ to }3\ \mu\text{g/kg/day}$ once daily on an empty stomach, titrated every 4 to 6 weeks based on serum TSH and free T4 levels. (Note: Endocrine treatment alone does not reverse mechanical slipping and must follow or accompany surgical stabilization).

1. Radiological Finding & Diagnosis:
   • Radiological Finding: Widening of the interpedicular distance with bifurcation/absence of the posterior spinous processes and failure of fusion of the vertebral laminae/posterior neural arches over the affected lumbosacral segments.
   • Diagnosis: Spina bifida cystica (Myelomeningocele / open spinal dysraphism).
2. Associated Manifestations:
   • Lower motor neuron flaccid paraparesis or paraplegia with variable sensory loss below the level of the lesion.
   • Congenital talipes equinovarus (CTEV / clubfoot), hip subluxation/dislocation, or arthrogryposis-like contractures.
   • Neurogenic bladder (urinary incontinence, retention, vesicoureteral reflux) and neurogenic bowel (lax anal sphincter, fecal incontinence).
   • Associated Chiari II malformation with progressive hydrocephalus.
3. Nutritional Factor & Prophylactic Protocols:
   • Factor: Periconceptional Maternal Folic Acid (Vitamin B9) deficiency.
   • Low-Risk / Routine Prophylaxis: $0.4\text{ mg (400 }\mu\text{g)/day}$ orally, starting at least 1 month prior to conception and continued through the end of the first trimester (12 weeks).
   • High-Risk Prophylaxis (previous child with NTD, maternal anticonvulsant therapy, pregestational diabetes): $4\text{ to }5\text{ mg/day}$ orally, starting at least 1 to 3 months prior to conception and continued through the first trimester.
4. Immediate Neonatal Management (First 24 Hours):
   • Keep infant in the prone or prone-lateral position to prevent mechanical pressure on the sac.
   • Cover the defect with sterile, warm isotonic saline-soaked non-adherent gauze and a protective plastic barrier to prevent desiccation and heat loss.
   • Initiate broad-spectrum intravenous antibiotics (e.g., Ampicillin $100\text{ mg/kg/day}$ IV in 2 divided doses plus Gentamicin $4\text{ mg/kg/day}$ IV once daily).
   • Strict avoidance of latex products (latex-free environment from birth) to prevent allergic sensitization.
   • Obtain baseline head circumference, cranial ultrasound for ventriculomegaly, and arrange urgent neurosurgical closure within 24 to 48 hours to minimize central nervous system infection.

1. Primary Clinical Diagnosis:
   • Clinical syndrome: Acute scrotum.
   • Primary surgical emergency: Left testicular torsion (extravaginal or intravaginal torsion of the spermatic cord).
2. Sensitive Physical Examination Sign:
   • Absent cremasteric reflex (sensitivity 96–99%).
   • Elicitation method: Lightly scratch or stroke the skin of the upper inner/anteromedial aspect of the ipsilateral thigh (supplied by the ilioinguinal nerve and genitofemoral nerve, L1–L2). The normal response is brisk contraction of the cremaster muscle resulting in ipsilateral testicular elevation of $\ge 0.5\text{ cm}$. Absence of this elevation supports the diagnosis of testicular torsion.
3. Differential Diagnoses of Acute Scrotum:
   • Torsion of the testicular appendage (appendix testis / hydatid of Morgagni)
   • Acute epididymitis or epididymo-orchitis
   • Traumatic hematocele / testicular rupture
   • Incarcerated or strangulated inguinoscrotal hernia
   • Henoch-Schönlein purpura (IgA vasculitis) with scrotal vasculitis
4. Definitive Surgical Management:
   • Immediate surgical exploration: Emergency scrotal exploration via a midline raphe or transverse hemiscrotal incision within the 6-hour window from symptom onset.
   • Detorsion and viability assessment: Untwisting the spermatic cord (typically counterclockwise for the left testis, "opening a book"), followed by wrapping in warm, saline-soaked gauze packs for 10–15 minutes to evaluate recovery of perfusion.
   • Orchidopexy: If viable, three-point fixation of the testis to the dartos pouch using non-absorbable monofilament sutures (e.g., 3-0 or 4-0 polypropylene) or slowly absorbable sutures (polydioxanone). If completely necrotic/non-viable, ipsilateral orchidectomy is performed.
   • Mandatory contralateral procedure: Prophylactic contralateral orchidopexy must always be performed during the same operative setting, because the underlying anatomic predisposing factor ("bell-clapper deformity"—high investiture of the tunica vaginalis onto the spermatic cord) is bilateral in over 50–80% of cases.

graph TD
    A[Acute Scrotum in Pediatric Emergency] --> B{Time from onset & Clinical Exam}
    B -->|Absent Cremasteric Reflex / High Riding Testis| C[High Suspicion: Testicular Torsion]
    B -->|Isolated Upper Pole Blue-Dot Sign / Intact Reflex| D[Appendix Testis Torsion]
    C --> E{Immediate Scrotal Exploration within 6 Hours}
    E -->|Torsion Confirmed & Testis Viable| F[Detorsion + Bilateral 3-Point Orchidopexy]
    E -->|Non-viable / Necrotic Testis| G[Ipsilateral Orchidectomy + Prophylactic Contralateral Orchidopexy]
    D --> H[Conservative: Rest, Scrotal Support, NSAIDs]

Color Doppler ultrasonography (CDUS) showing absent or diminished intratesticular arterial blood flow has high sensitivity (85–95%), but should never delay emergency surgical exploration if clinical index of suspicion is high.

1. Most Likely Diagnosis:
   • Thyroglossal duct cyst (TGDC).
2. Bedside Diagnostic Maneuvers:
   • Movement with deglutition: The mass moves cephalad (upward) when the child swallows, due to its anatomic attachment via the thyroglossal tract to the hyoid bone and the pretracheal fascia.
   • Movement with tongue protrusion: With the patient's jaw held open, active protrusion of the tongue causes the mass to elevate and retract cephalad/inward, because the persistent thyroglossal tract remains embryologically anchored to the foramen cecum at the base of the tongue.
3. Mandatory Pre-operative Investigations & Objectives:
   • High-Resolution Ultrasonography (USG) of the neck: Confirms the cystic nature of the mass and crucially verifies the presence of normal orthotopic functional thyroid tissue in the pretracheal thyroid bed (rules out an ectopic thyroid gland, which may be the patient's only functioning thyroid tissue in 1–2% of cases).
   • Serum Thyroid Function Tests (TSH, Free T4): Evaluates baseline functional euthyroid status before surgical intervention.
   • Radionuclide Thyroid Scintigraphy ($^{99m}\text{Tc}$-pertechnetate or $^{123}\text{I}$ scan): Indicated if normal orthotopic thyroid gland tissue is absent, ambiguous, or questionable on high-resolution ultrasonography to prevent inadvertent surgical athyreosis and subsequent lifelong myxedema.
4. Definitive Surgical Management:
   • Procedure: Sistrunk operation (modified Sistrunk procedure).
   • Essential structures resected:
     • En bloc excision of the cyst.
     • Excision of the central body of the hyoid bone (central 1.0 to 1.5 cm segment).
     • Core of surrounding base-of-tongue musculature (genioglossus and hyoglossus muscle fibers) surrounding the tract upward to the mucosa of the foramen cecum to clear microscopic arborized secretory remnants and prevent recurrence (reduces recurrence rate from >50% with simple enucleation to <3–5%).

1. Severity Classification:
   • UTD Antenatal Classification: UTD A2–3 (High Risk) (defined as APRPD $\ge 10\text{ mm}$ at $\ge 28$ weeks gestation, with associated peripheral caliceal dilation and ureteral dilation).
   • SFU Grading System: SFU Grade 4 (pelvicalyceal dilation with marked caliceal ballooning, flattening of renal papillae, and cortical parenchymal thinning).
2. Differential Diagnoses:
   • Congenital primary obstructive megaureter (ureterovesical junction [UVJ] obstruction)
   • High-grade primary vesicoureteral reflux (refluxing megaureter, VUR Grade IV or V)
   • Primary non-obstructive, non-refluxing megaureter (idiopathic megaureter)
   • Ectopic ureter or obstructing intravesical/ectopic ureterocele (often associated with an upper pole duplex moiety)
   • Obstructing posterior urethral valves (PUV) with unilateral severe refluxing dysplasia (VURD syndrome; less likely in the setting of normal bladder and normal amniotic fluid volume, but remains a consideration in male fetuses).
3. Antenatal Monitoring Parameters & Scanning Frequency:
   • Monitoring interval: Serial ultrasound examination every 3 to 4 weeks (monthly) until delivery.
   • Key ultrasonographic parameters:
     • Anteroposterior renal pelvic diameter (APRPD), caliceal blunting, and ureteral diameter progression.
     • Renal parenchymal integrity: cortical thickness, parenchymal echogenicity (relative to fetal liver), and presence of subcortical renal cysts (indicating dysplasia).
     • Amniotic fluid volume (AFI or single deepest vertical pocket [DVP]) to detect developing oligohydramnios.
     • Urinary bladder parameters: dynamic bladder cycling, wall thickness ($\le 2\text{ mm}$ is normal), and bladder base/urethral morphology ("keyhole sign").
4. Postnatal Evaluation Protocol:
   • Initial Postnatal Ultrasound: Perform at 48 to 72 hours of life (Day 3–7). Avoid scanning in the first 48 hours because transient physiological neonatal oliguria and dehydration can cause false underestimation of the true degree of hydronephrosis.
   • Continuous Antibiotic Prophylaxis (CAP):
     • Initiate on Day 1 of life due to high risk of febrile urinary tract infections (UTIs) associated with ureteral dilation (UTD P3).
     • Drug & Regimen: Oral Amoxicillin $10\text{ mg/kg}$ once daily at bedtime for neonates $<2$ months of age; transition to Trimethoprim-Sulfamethoxazole ($2\text{ mg/kg/dose}$ of trimethoprim) or Cephalexin ($10\text{ mg/kg/dose}$) once daily at bedtime after 2 months of age.
   • Definitive Functional Imaging:
     • Micturating Cystourethrogram (MCUG/VCUG): Perform at 4 to 6 weeks of life under prophylactic antibiotic coverage to rule out vesicoureteral reflux and urethral pathology.
     • Diuretic Dynamic Renography ($^{99m}\text{Tc}$-MAG3 scan with F+20 Furosemide protocol): Perform at 6 to 12 weeks of life (allowing for postnatal nephron maturation and glomerular filtration rate rise) to quantify differential renal function (DRF, normal $>45\%$) and evaluate drainage kinetics (clearance half-time $T_{1/2} > 20\text{ minutes}$ signifies true mechanical obstruction).